Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384156985> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4384156985 endingPage "180" @default.
- W4384156985 startingPage "179" @default.
- W4384156985 abstract "WHO began immunising children against polio in low-income and middle-income countries (LMICs) in 1974, through the Expanded Programme on Immunisation, using a trivalent oral poliovirus vaccine (tOPV)—three doses during infancy. In 1984, a dose at birth was added. Polio was not controlled in LMICs despite the four-dose tOPV schedule. Hence, in 1988, WHO proposed, and the World Health Assembly unanimously passed, a resolution to eradicate polio by 2000.1WHOGlobal eradication of poliomyelitis by the year 2000.https://apps.who.int/iris/bitstream/handle/10665/164531/WHA41_R28_eng.pdf?sequence=1&isAllowed=yDate: May 13, 1988Date accessed: March 26, 2023Google Scholar In our inequitable world, aiming for equity in polio prevention was altruism that inspired everyone, particularly financial donors. Eradication meant reducing the incidence of polio to zero and interrupting poliovirus transmission, globally.2Dowdle WR The principles of disease elimination and eradication.MMWR Morb Mortal Wkly Rep. 1999; 48: 23-27Google Scholar Reaching country-level zero polio and zero poliovirus transmission is defined as elimination.2Dowdle WR The principles of disease elimination and eradication.MMWR Morb Mortal Wkly Rep. 1999; 48: 23-27Google Scholar Before 1988, Sweden, Iceland, Finland, and Norway had eliminated polio using the inactivated poliovirus vaccine (IPV), with three doses during infancy and one or more boosters later.3Böttiger M The elimination of polio in the Scandinavian countries.Public Health Rev. 1993; 21: 27-33PubMed Google Scholar Denmark achieved polio elimination using a sequential schedule of IPV followed by the oral poliovirus vaccine (OPV).3Böttiger M The elimination of polio in the Scandinavian countries.Public Health Rev. 1993; 21: 27-33PubMed Google Scholar These experiences provided proof of principle and a one-stage, rapid, polio elimination model. For achieving zero incidence of polio by 2000, the Global Polio Eradication Initiative (GPEI) should have transitioned to the IPV in LMICs and phased out the OPV, since it causes vaccine associated paralytic polio (VAPP) in an occasional vaccinated child or unvaccinated contact.4Nkowane BM Wassilak SGM Orenstein WA et al.Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984.JAMA. 1987; 257: 1335-1340Crossref PubMed Google Scholar Indeed, OPV use is incompatible with polio eradication. Several countries had achieved zero incidence of polio caused by wild polioviruses using tOPV but had to switch to IPV to avoid VAPP and reach polio elimination. This method was a slow, two-phase polio elimination model. France discontinued OPV in 1988, Germany in 1989, and the USA in 2000, all achieving elimination within 1 year of IPV switch. Unfortunately, the GPEI could not manage to end wild poliovirus using tOPV because of its well documented suboptimal efficacy in tropical and subtropical LMICs.5Patriarca PA Wright PF John TJ Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.Rev Infect Dis. 1991; 13: 926-939Crossref PubMed Google Scholar Thus the two-phase model was inapplicable for polio eradication. Only one tactic could eradicate polio: to introduce IPV and when 80% coverage of three doses of IPV is reached, to phase out OPV, country by country. This method required a policy shift in the early 1990s so that the industry could ramp up IPV production. Continuing use of the OPV beyond 1999, without ensuring protection from polio with IPV, has resulted in: between 8800 and 17 600 children being paralysed by VAPP;6John TJ A developing country perspective on vaccine-associated paralytic poliomyelitis.Bull World Health Organ. 2004; 82: 53-57PubMed Google Scholar sporadic polio, caused by vaccine-derived polioviruses types 1, 2, or 3, and polio outbreaks, caused by these circulating viruses, having paralysed nearly 5000 children; and wild poliovirus not yet being eliminated in Afghanistan and Pakistan where a section of society do not trust the OPV, particularly when given in repeated house-to-house campaigns. Since the future polio-eradicated world can use only the IPV, transition to IPV is the sensible way forward. This policy shift must be announced without delay so that supply, especially of combination vaccines containing IPV, can be expedited. No child is recorded to have developed polio after receiving three doses of IPV during infancy. We appeal to the GPEI, donors, and global opinion leaders, to ensure that no more polio is caused in the name of its eradication. The promised equity must be delivered. We declare no competing interests. TJJ is a retired employee of the Christian Medical College." @default.
- W4384156985 created "2023-07-14" @default.
- W4384156985 creator A5012323156 @default.
- W4384156985 creator A5018534101 @default.
- W4384156985 creator A5059836266 @default.
- W4384156985 creator A5070220426 @default.
- W4384156985 date "2023-07-01" @default.
- W4384156985 modified "2023-09-30" @default.
- W4384156985 title "How to avoid causing polio in the name of its eradication" @default.
- W4384156985 cites W2072881891 @default.
- W4384156985 cites W4292672029 @default.
- W4384156985 doi "https://doi.org/10.1016/s0140-6736(23)01069-3" @default.
- W4384156985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37453743" @default.
- W4384156985 hasPublicationYear "2023" @default.
- W4384156985 type Work @default.
- W4384156985 citedByCount "0" @default.
- W4384156985 crossrefType "journal-article" @default.
- W4384156985 hasAuthorship W4384156985A5012323156 @default.
- W4384156985 hasAuthorship W4384156985A5018534101 @default.
- W4384156985 hasAuthorship W4384156985A5059836266 @default.
- W4384156985 hasAuthorship W4384156985A5070220426 @default.
- W4384156985 hasBestOaLocation W43841569851 @default.
- W4384156985 hasConcept C119599485 @default.
- W4384156985 hasConcept C126322002 @default.
- W4384156985 hasConcept C127413603 @default.
- W4384156985 hasConcept C151492266 @default.
- W4384156985 hasConcept C159047783 @default.
- W4384156985 hasConcept C2522874641 @default.
- W4384156985 hasConcept C2779134260 @default.
- W4384156985 hasConcept C2779631682 @default.
- W4384156985 hasConcept C2909656726 @default.
- W4384156985 hasConcept C4870876 @default.
- W4384156985 hasConcept C71924100 @default.
- W4384156985 hasConcept C761482 @default.
- W4384156985 hasConcept C99454951 @default.
- W4384156985 hasConceptScore W4384156985C119599485 @default.
- W4384156985 hasConceptScore W4384156985C126322002 @default.
- W4384156985 hasConceptScore W4384156985C127413603 @default.
- W4384156985 hasConceptScore W4384156985C151492266 @default.
- W4384156985 hasConceptScore W4384156985C159047783 @default.
- W4384156985 hasConceptScore W4384156985C2522874641 @default.
- W4384156985 hasConceptScore W4384156985C2779134260 @default.
- W4384156985 hasConceptScore W4384156985C2779631682 @default.
- W4384156985 hasConceptScore W4384156985C2909656726 @default.
- W4384156985 hasConceptScore W4384156985C4870876 @default.
- W4384156985 hasConceptScore W4384156985C71924100 @default.
- W4384156985 hasConceptScore W4384156985C761482 @default.
- W4384156985 hasConceptScore W4384156985C99454951 @default.
- W4384156985 hasIssue "10397" @default.
- W4384156985 hasLocation W43841569851 @default.
- W4384156985 hasLocation W43841569852 @default.
- W4384156985 hasOpenAccess W4384156985 @default.
- W4384156985 hasPrimaryLocation W43841569851 @default.
- W4384156985 hasRelatedWork W1783287906 @default.
- W4384156985 hasRelatedWork W2091893535 @default.
- W4384156985 hasRelatedWork W2158062205 @default.
- W4384156985 hasRelatedWork W2735657752 @default.
- W4384156985 hasRelatedWork W2799743080 @default.
- W4384156985 hasRelatedWork W3159926165 @default.
- W4384156985 hasRelatedWork W4255162284 @default.
- W4384156985 hasRelatedWork W4280493380 @default.
- W4384156985 hasRelatedWork W4292140543 @default.
- W4384156985 hasRelatedWork W4301019058 @default.
- W4384156985 hasVolume "402" @default.
- W4384156985 isParatext "false" @default.
- W4384156985 isRetracted "false" @default.
- W4384156985 workType "article" @default.